How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
Show:
| TripSit | Pharmacology | DrugCentral | ||
|---|---|---|---|---|
| Classification | ||||
| Safety | ||||
| Duration | ||||
| Onset | 30–90 minutes | — | — | |
| Total | 2–6 hours | — | — | |
| Pharmacology | ||||
| Receptor activity | — | Amine oxidase [flavin-containing] ASigma non-opioid intracellular receptor 1Sigma intracellular receptor 2Amine oxidase [flavin-containing] BUnchecked | MAOAHTR1AMAOBKCNH2 | ≠ |
| Half-life | — | 1-2 hours (4 hours in cirrhotic patients); metabolites are renally excreted Elimination: 1.5 hours (4 hours in cirrhotic patients). | — | |
| Protein binding | — | Approximately 50% (primarily to albumin) | — | |
TripSit summary
A reversible MAOI which is prescribed to treat depression and anxiety. Its reversibility and short-acting length of effects often means it is used in "pharmahuasca" preparations.
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.